scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1521-6616(02)00025-6 |
P698 | PubMed publication ID | 12672401 |
P2093 | author name string | C E Hack | |
A B J Groeneveld | |||
A W J Bossink | |||
A N Tacx | |||
G J van Mierlo | |||
P2860 | cites work | Lipid mediators in the pathophysiology of critical illness | Q33916372 |
Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis | Q34003850 | ||
Immunological therapy of sepsis: experimental therapies | Q34221740 | ||
Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection | Q35512179 | ||
Role of the classical pathway of complement activation in experimentally induced polymicrobial peritonitis | Q39522748 | ||
IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses | Q39797207 | ||
Fever in hospitalized patients. With special reference to the medical service | Q39804722 | ||
Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables | Q40633286 | ||
Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options | Q40785303 | ||
Phospholipase A2 from plasma of patients with septic shock is associated with high-density lipoproteins and C3 anaphylatoxin: some implications for its functional role | Q41369339 | ||
Local inflammatory responses following bronchial endotoxin instillation in humans | Q42505703 | ||
Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease. | Q43464081 | ||
Role of C5a in multiorgan failure during sepsis | Q43516359 | ||
Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study | Q43750575 | ||
Protective effects of C5a blockade in sepsis | Q44260666 | ||
Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2. | Q45126128 | ||
Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis | Q45254421 | ||
Both C3a and C3a(desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells | Q48023951 | ||
Gender differences in human sepsis | Q50856857 | ||
Sepsis and serum cytokine concentrations. | Q51546879 | ||
Serum Cytokine Levels in Human Septic Shock | Q64127587 | ||
High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines | Q64132927 | ||
Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans | Q67531680 | ||
Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera | Q70141839 | ||
Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease | Q70531795 | ||
Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia | Q70838980 | ||
Local Pseudomonas instillation induces contralateral lung injury and plasma cytokines | Q71078876 | ||
Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture | Q71580295 | ||
Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome | Q72939014 | ||
Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome | Q73014103 | ||
Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice | Q73071125 | ||
The effect of C1-esterase inhibitor in definite and suspected streptococcal toxic shock syndrome. Report of seven patients | Q73318544 | ||
Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis | Q73524149 | ||
The value of immune modulating parameters in predicting the progression from peritonitis to septic shock | Q73545810 | ||
Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis | Q73730784 | ||
Complement activation in patients with sepsis is in part mediated by C-reactive protein | Q74005669 | ||
Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria? | Q74666038 | ||
Anti-TNF treatment of baboons with sepsis reduces TNF-alpha, IL-6 and IL-8, but not the degree of complement activation | Q77579690 | ||
P433 | issue | 2 | |
P1104 | number of pages | 10 | |
P304 | page(s) | 106-115 | |
P577 | publication date | 2003-02-01 | |
P1433 | published in | Clinical Immunology | Q15752921 |
P1476 | title | Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection | |
P478 | volume | 106 |
Q97529284 | A Furosemide Excretion Stress Test Predicts Mortality in Mice After Sepsis and Outperforms the Furosemide Stress Test During Vasopressin Administration |
Q26784268 | Activated Complement Factors as Disease Markers for Sepsis |
Q35600970 | Chronic sepsis mortality characterized by an individualized inflammatory response |
Q50591830 | Circulating microparticles and procoagulant activity in elderly patients |
Q21194921 | Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia |
Q97070834 | Complement levels in patients with bloodstream infection due to Staphylococcus aureus or Gram-negative bacteria |
Q81077799 | Complement-induced Impairment of the Innate Immune System During Sepsis |
Q35850641 | Complement-induced impairment of the innate immune system during sepsis |
Q43103990 | Correlation between body temperature, blood pressure and plasmatic nitric oxide in septic patients |
Q26741263 | Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis |
Q79339619 | Dietary fish oil enhances adhesion molecule and interleukin-6 expression in mice with polymicrobial sepsis |
Q33377675 | Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a. |
Q34049911 | Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels. |
Q34597721 | Effect of ceftriaxone on the outcome of murine pyelonephritis caused by extended-spectrum-β-lactamase-producing Escherichia coli. |
Q43127216 | Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypass |
Q39089174 | HIV Coinfection Enhances Complement Activation During Sepsis |
Q35689431 | Hematopoietic stem-progenitor cells restore immunoreactivity and improve survival in late sepsis |
Q79180911 | Indicators of sepsis severity |
Q35536376 | Inflammatory response associated with pulmonary complications in non-HIV immunocompromised patients |
Q35170010 | MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-α during TLR4-induced gene reprogramming |
Q41902829 | Model of polymicrobial peritonitis that induces the proinflammatory and immunosuppressive phases of sepsis |
Q36209804 | Physiological functions should be considered as true end points of nutritional intervention studies |
Q61811233 | Pro-inflammatory agents released by pathogens, dying host cells, and neutrophils act synergistically to destroy host tissues: a working hypothesis |
Q40381150 | Relative roles of complement factor 3 and mannose-binding lectin in host defense against infection |
Q35075795 | Role of fibronectin-binding proteins A and B in in vitro cellular infections and in vivo septic infections by Staphylococcus aureus |
Q35927426 | Route and type of nutrition and surgical stress influence secretory phospholipase A2 secretion of the murine small intestine. |
Q35385515 | Secretory phospholipase A₂ responsive liposomes |
Q37655890 | Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding |
Q33973581 | Several Cytokines and Protein C Levels with the Apache II Scoring System for Evaluation of Patients with Sepsis |
Q49080371 | The hemodynamics of human septic shock relate to circulating innate immunity factors |
Q27027974 | The role of complement system in septic shock |
Search more.